Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Beidler
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled Study
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Related publications
Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): Study Protocol for a Randomized Placebo-Controlled Trial in Ugandan Children With Sickle Cell Anemia
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
A Phase 1b Randomized, Placebo-Controlled Clinical Trial With SNF472 in Hemodialysis Patients
British Journal of Clinical Pharmacology
Pharmacology
A Novel, Highly Potent and Selective Phosphodiesterase-9 Inhibitor for the Treatment of Sickle Cell Disease
Haematologica
Hematology
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Therapeutic Effect of Oral CF101 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Immunome Research
Work Productivity Improvement Associated With Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results of a Phase 3, Randomized, Controlled Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Indobufen in the Prevention of Thromboembolic Complications in Patients With Heart Disease. A Randomized, Placebo-Controlled, Double-Blind Study
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
Hepatitis Monthly
Hepatology
Infectious Diseases
